Healthcare: Air Liquide Announces the Acquisition of a Hygiene Specialist in Brazil
05 February 2016 - 6:30PM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) announces the acquisition by its
subsidiary Schülke, a specialist in hygiene and hospital
disinfection, of Vic Pharma, a company operating in this sector in
Brazil.
Founded in 1990, Vic Pharma is the second largest independent
player in the Brazilian hygiene market and counts more than 100
employees. It offers a broad range of hygiene products for
disinfecting surfaces, instruments and medical devices, as well as
antiseptic solutions for pre- or post-operative care. Present
mainly in the hospital and medical settings, the company generated
revenue of around € 8 million in 2015. It distributes its product
range to hospitals through a wide distribution network that covers
the entire country.
The Group will call on the existing teams to pursue the
deployment and distribution of Vic Pharma product lines, to which
the Schülke hygiene product lines will gradually be added.
Thanks to this acquisition, made via a majority equity stake
(75%), Air Liquide reinforces its position in the South
American Healthcare market.
Pascal Vinet, Vice-President Global Healthcare
Operations and member of Air Liquide group’s Executive Committee,
commented: “With this acquisition Air Liquide Healthcare
pursues the development of its Hygiene activity, extending its
geographic reach to South America. The Group thus strengthens its
Healthcare business in this region.”
Air Liquide Healthcare
supplies medical gases, home healthcare services, hygiene
products, medical equipment and specialty ingredients.
In 2014, it served over 7,500 hospitals and more than
1 million patients at home throughout the world.
The Group’s Healthcare business reached € 2,570 million in
revenues in 2014, with the support of its 12,000
employees.
Schülke in brief
Subsidiary of the Air Liquide group within the Healthcare
activity and expert in hospital disinfection, Schülke
designs and supplies since more than 125 years a wide range of
disinfectants and antiseptics mainly for medical environment
to actively contribute to patient safety. Present in 80
countries through its affiliates and network of distributors,
Schülke employs over 900 people around the world, including
70 researchers. www.schuelke.com
World leader in gases, technologies and services for Industry
and Health, Air Liquide is present in 80 countries with more than
50,000 employees and serves more than 2 million customers and
patients. Oxygen, nitrogen and hydrogen have been at the core of
the company’s activities since its creation in 1902. Air Liquide’s
ambition is to be the leader in its industry, delivering long-term
performance and acting responsibly.
Air Liquide ideas create value over the long term. At the core
of the company’s development are the commitment and constant
inventiveness of its people.
Air Liquide anticipates the challenges of its markets, invests
locally and globally, and delivers high-quality solutions to its
customers and patients, and the scientific community.
The company relies on competitiveness in its operations,
targeted investments in growing markets and innovation to deliver
profitable growth over the long-term.
Air Liquide’s revenues amounted to € 15.4 billion in 2014, and
its solutions that protect life and the environment represented
more than 40% of sales. Air Liquide is listed on the Paris Euronext
stock exchange (compartment A) and is a member of the CAC 40
and Dow Jones Euro Stoxx 50 indexes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160204006250/en/
Corporate CommunicationsCaroline Philips, +33 (0)1 40 62
50 84Aurélie Wayser-Langevin, +33 (0)1 40 62 56 19orInvestor
RelationsAude Rodriguez, +33 (0)1 40 62 57 08Erin Sarret, +33
(0)1 40 62 57 37Louis Laffont, +33 (0)1 40 62 57 18orAir Liquide
Healthcare CommunicationsMuriel Doucet, +33(0)1 49 69 46 46
C3 AI (NYSE:AI)
Historical Stock Chart
From Jun 2024 to Jul 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Jul 2023 to Jul 2024